BUFFALO, N.Y. – The American Heart ... management for the condition in decades. Differences between children and adult cardiomyopathies The statement emphasizes important differences among treatment ...

which led to the first improvement in clinical outcomes of medical management for the condition in decades. The statement emphasizes important differences among treatment types for cardiomyopathies ...

Objectives: Nesiritide (synthetic B-type natriuretic peptide) has been shown to be effective in the management of acute decompensated heart failure in adults. The role of nesiritide in pediatric ...

In the PANORAMA-HF trial, children receiving sacubitril ... outcomes than those who received medical management alone, including lower rates of heart failure hospitalization and death.

Cousino, PhD (Michigan Medicine, Ann Arbor), a pediatric psychologist specializing in the ... patient-led decision-making about heart disease management. Only 18.9% wanted their doctors to make the ...

Heart transplantation is the current standard of care for end-stage pediatric heart failure, if they can survive the high waitlist mortality (13-17%). As a viable alternative, the implementation of ...

Australia's Murdoch Children's Research Institute is helping scientists use stem cell medicine and artificial intelligence to develop precision therapies for pediatric heart disease, the leading ...

Dr. Kevin Watt, team leader of the Heart Regeneration and Disease Laboratory at the Murdoch Children’s Research Institute (MCRI) in Melbourne, Australia, understands this concept deeply.

The Pediatric Heart Transplant Study (PHTS) has recognized the Children’s of Alabama/UAB Pediatric Transplant and Heart Failure Team with the prestigious PHTS VANGUARD CENTER Award. This recognition ...

Dr. Kevin Watt, team leader of the Heart Regeneration and Disease Laboratory at the Murdoch Children’s Research Institute (MCRI) in Melbourne, Australia, understands this concept deeply.